Pasithea Therapeutics Corp. (KTTA) - Pangali P/E
Pasithea Therapeutics (KTTA) bases its business on managing a network of centers that utilize ketamine infusion to treat depression and chronic pain. The company's operations are exposed to risks of supply chain disruptions for rare reagents and delays in global software testing. Historical price action on GURU.Markets shows a value of -0.70, while the staff of leading neurobiologists remains stable and committed to scientific goals.
Rincian metrik komprehensif lan analitis pasitheaclinics.com (KTTA)
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Modal Pasithea Therapeutics|KTTA - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Pasithea Therapeutics|KTTA - Gunggung utang perusahaan|Utang-utang marang nilai buku Pasithea Therapeutics Corp|KTTA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Pasithea Therapeutics|Rasio jangkoan perantara pasitheaclinics.com
- rincian bathi lan kelipatan pasar:
KTTA - Penghasilan resik|Bathi resik mangsa ngarep Pasithea Therapeutics|KTTA - Pangali P/E|Pangali mangsa ngarep rega marang bathi Pasithea Therapeutics|KTTA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pasithea|KTTA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Pasithea Therapeutics|KTTA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan pasitheaclinics.com|KTTA - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Pasithea Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:KTTA (Pasithea Therapeutics Corp.)
Pasithea Therapeutics (KTTA) is optimizing biocomponent supply chains for the development of psychiatric disorder treatments. The ratio of market capitalization to net income, reflected in the company's P/E ratio dynamics, measures the premium for the future success of clinical trials. This coefficient demonstrates investors' willingness to pay a premium per unit of current earnings. This chart allows for the differentiation of accounting metrics from the asset's real value, which determines the fair cost of capital under high-risk conditions.
Pesaing wigati
Rasio rega marang bathi BIIB|Pangali P/E NBIX|Regencell (RGC) - Rasio kapitalisasi marang bathi resik|Rasio rega marang bathi axsome.com AXSM|Pangali P/E ACADIA Pharmaceuticals ACAD|XENE - Rasio rega marang bathi|Periode bali modal bisnis Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Rasio rega marang bathi|CPRX (Catalyst Pharmaceuticals) - Rasio rega marang bathi|DNLI (denalitherapeutics.com) - Pangali P/E|Pangali rega marang bathi HRMY (Harmony Biosciences Holdings, Inc.)|Pangali P/E BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Nilai perusahaan marang bathi resik|Pangali P/E TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalisasi marang bathi resik|anavex.com - Pangali P/E|Nilai perusahaan marang bathi resik CBLL (CeriBell, Inc.)|PRTA: Pangali P/E|Pangali rega marang bathi ALEC|ANNX (Annexon Biosciences Inc.) - Pangali P/E|omeros.com - Kapitalisasi marang bathi resik|Rasio rega marang bathi Neurogene (NGNE)|Periode bali modal bisnis AC Immune SA|Pangali P/E VYGR (voyagertherapeutics.com)|Pangali P/E Neumora NMRA|Scilex Holding - Pangali P/E|Kapitalisasi marang bathi Tevogen Bio Inc.|Alpha Cognition (ACOG) - Rasio rega marang bathi|cogrx.com (CGTX) - Pangali P/E|Rasio rega marang bathi Inhibikase Therapeutics|Cassava (SAVA) - Periode bali modal bisnis|Rasio rega marang bathi Assertio Therapeutics (ASRT)|Periode bali modal bisnis Coya|Vistagen - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OVID|Acumen Pharmaceuticals Inc. - Pangali P/E|Kapitalisasi marang bathi CervoMed Inc|ATHE: Pangali P/E|Koefisien rega marang bathi Clene Nanomedicine|Rasio rega marang bathi PepGen Corp|Jupiter Neurosciences (JUNS) - Periode bali modal bisnis|Rasio rega marang bathi Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalisasi marang bathi|gracetx.com - Koefisien rega marang bathi|AIFF: Pangali rega marang bathi|Klotho Neurosciences - Pangali P/E|NRSN (NeuroSense Therapeutics Ltd.) - Pangali rega marang bathi|Reviva Pharmaceuticals (RVPH) - Rasio rega marang bathi|MTVA (MetaVia Inc.) - Rasio rega marang bathi|Rasio rega marang bathi NeurAxis, Inc|Rasio rega marang bathi HSDT|Pangali P/E PASG|Periode bali modal bisnis Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Koefisien rega marang bathi|Pangali P/E Athira ATHA|Addex Therapeutics - Pangali P/E|ALZN - Pangali P/E|Cyclerion (CYCN) - Rasio rega marang bathi|Protagenic (PTIX) - Pangali P/E|Rasio rega marang bathi Cortigent|Kapitalisasi marang bathi Avenue Therapeutics Inc. ATXI|Rasio rega marang bathi brainstorm-cell.com (BCLI)|Koefisien rega marang bathi Cara Therapeutics, Inc CARA|Pangali P/E CHRO (chromocell.com)|Nilai perusahaan marang bathi resik ELYM|Intra-Cellular Therapies Inc. - Pangali P/E|Kapitalisasi marang bathi Longboard Pharmaceuticals Inc|Marinus (MRNS) - Rasio rega marang bathi|NKGN - Periode bali modal bisnis|Rasio rega marang bathi NeuroBo Pharmaceuticals|SAGE: Nilai perusahaan marang bathi resik|Pangali P/E SNPX|Trevena Inc. - Pangali rega marang bathi|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Rasio rega marang bathi|Cerevel Therapeutics - Pangali P/E
